Latest Breaking News On - Brianm culley - Page 5 : comparemela.com

Lineage Cell Therapeutics Expected to Be Added to Russell 3000® Index

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported that the Company is expected to be added to the. | May 22, 2023

City ofUnited kingdomUnited statesBrianm culleyLondon stock exchange groupRoche groupLineage cell therapeutics incLineage cell therapeuticsLondon stock exchangeCell therapeuticsNc stock exchangePress releaseO lctx us53566p1093

Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)

Award Will Support 1st Annual Spinal Cord Injury Investor Symposium To Be Held June 29, 2023 . | May 9, 2023

United statesBrianm culleyCalifornia institute for regenerative medicineLineage cell therapeutics incChristopher dana reeve foundationCalifornia stem cell agencyRoche groupLineage cell therapeuticsCalifornia instituteRegenerative medicineAnnual spinal cord injury investor symposiumDana reeveEducation conferenceStem cell agencyAnnual spinal cord injury investorAnnual spinal cord injury investor symposiumwill

Lineage to Present at 2023 AAPS National Biotechnology Conference

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, Lineage’s Chief. | April 18, 2023

United statesBrianm culleySebastian guelmanPhiladelphia marriott downtown hotelGenentech incNational biotechnology conferenceRoche groupAdvances in therapeutic development across modalitiesTakeda pharmaceutical company ltdLineage cell therapeutics incAmerican association of pharmaceutical scientistsLineage cell therapeuticsChief executive officerPharmaceutical scientistsEastern timeCellular therapy symposium

Lineage and the Christopher & Dana Reeve Foundation Proudly Present the 1st Annual Spinal Cord Injury Investor Symposium

Inaugural Event on June 29, 2023, at the Sanford Consortium for Regenerative Medicine . | March 30, 2023

United statesSalk instituteSan diegoBrianm culleyJoseph pantginisJack allenRichardg fesslerJake javierMarco baptistaJerod niederAbbvie incSidney kimmel medical collegeSalk institute for biologicalCalifornia institute for regenerative medicineAdministration for community livingChristopher dana reeve foundation

Eterna Therapeutics (ERNA) Enters Into Option and License Agreement with Lineage Cell Therapeutics to Develop Hypoimmune Pluripotent Cell Lines for Multiple Neurology Indications

Eterna Therapeutics (ERNA) Enters Into Option and License Agreement with Lineage Cell Therapeutics to Develop Hypoimmune Pluripotent Cell Lines for Multiple Neurology Indications
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Matt angelBrianm culleyLineage cell therapeutics incExchange commissionEterna therapeutics incSecurities exchangeRoche groupLineage cell therapeuticsLooking statementsthisSecurities actSecurities exchange actPrivate securities litigation reform actAnnual reportQuarterly reportsCurrent reports